Cannabis Research: Diabetes Posted on 15 Jan 13:41
Cannabis Research: Diabetes
Diabetes mellitus is a group of diseases that is most commonly associated with a lack of insulin production, causing the blood sugar level is regulated wrong. There are two main types of diabetes, type 1 diabetes and type 2 diabetes. Patients who suffer from Type 1 diabetes, can ever produce no own natural insulin and are dependent on medication to survive. Type 2 diabetes patients do not produce enough insulin to support their body. This is a less severe form and can often be controlled with a strict diet. Untreated diabetes can lead to kidney failure, blindness, amputations and death.
To this end, studies carried out:
1) Cannabinoids block tactile allodynia in diabetic mice without attenuation of its antinociceptive effect. (Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect - 2004)
Caused by diabetes nerve pain is one of the most common causes of chronic pain. However, diabetics are less sensitive to the effects of analgesic drugs such as morphine and other opiates. This leaves the sufferer few options. This study was designed to assess the efficacy of cannabinoids in treating this type of pain. Through testing on diabetic mice found that cannabinoids may have a positive effect on pain reduction. Published in the "U.S. National Library of Medicine."
2) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (cannabidiol Lowers incidence of diabetes in non-obese diabetic mice - 2006)
This study was aimed to find out whether the cannabinoid CBD has an effect on the rate of diabetes-prone mice occurs in type 1 diabetes. It has been found that the onset of diabetes from a baseline of 86% in an untreated group to 30% in a group of mice treated with CBD, decreased. Published in "IngentaConnect."
3) Neuroprotective and blood-retinal barrier protective effects of cannabidiol in experimental diabetes. (Neuroprotective and Blood-Retinal Barrier-Preserving Effects if cannabidiol in experimental Diabetes2006)
This study examines how the non-psychoactive cannabinoid CBD may be applied to reduce damage to the retina caused by diabetes. Here, it was found that CBD inflammation, neurotoxicity and blood-retina in diabetic animals reduced expiration, indicating that the drug may be used to prevent the diabetic retinopathy. Published in the "U.S. National Library of Medicine.